Hospital Onset Bacteremia

2025 reporting period
  2026 Reporting Period 
Quality Measure  Hospital-Onset Bacteremia & Fungemia Outcome Measure 
NHSN Module  Bacteremia & Fungemia Surveillance Module
Measure Version  Version 1 
NHSN Protocol  2026 Bacteremia & Fungemia Surveillance Protocol
NHSN Module Description  The NHSN Bacteremia & Fungemia Surveillance Module provides a mechanism for automated reporting of bacteremia and fungemia events as part of patient-safety and quality improvement efforts. It provides acute care hospitals with an approach for tracking a broad scope of bloodstream infections, leveraging Healthcare Level Seven International® (HL7®) Fast Healthcare Interoperability Resources® (FHIR®) to enable algorithmic determinations from clinical data available in electronic health records (EHRs).  
Short Name  HOB 
CBE ID*  3686 
Measure Steward  CDC NHSN 
Measure Description  This measure is an annual risk-adjusted standardized infection ratio (SIR) of Hospital-Onset Bacteremia & Fungemia events (HOB). The HOB SIR is reported annually and is calculated by dividing the number of observed HOB events divided by the number of predicted HOB events. 
Measure Scoring  Ratio 
Measure Type  Outcome 
Stratification  None 
Risk Adjustment 
  • Community-onset bacteremia rate per 100 admissions 
  • Hospital-onset test intensity 
  • Community-onset test intensity 
  • Hospital-onset test prevalence 
  • ICU admissions, % 
  • Mean length-of-stay 
  • Bed size 
  • Patients aged 41-64y, % 
  • Patients aged >80 y, % 

 

Reference: Yu KC, Ye G, Edwards JR, et al. Hospital-onset bacteremia and fungemia: An evaluation of predictors and feasibility of benchmarking comparing two risk-adjusted models among 267 hospitals. Infect Control Hosp Epidemiol 2002;43(10):1317–1325. 

Rationale  Bloodstream infections (BSIs) are associated with high morbidity and mortality [1]. Some BSIs are classified as Central Line-Associated Bloodstream Infections (CLABSIs), which has been a focus of surveillance and infection prevention efforts for many years. As a result, CLABSIs have decreased from historical levels [2]. Less attention has been given to the prevention of bloodstream infections not associated with central lines. The establishment of the HOB measure is essential for expanding the understanding, prevention, and management of all hospital-onset bloodstream infections. By systematically collecting and analyzing data, healthcare systems can improve patient outcomes, inform public health strategies, and ultimately reduce the burden of bacteremia and fungemia in the community.  

References: 

  1. Surbhi Leekha, Robinson GL, Jacob JT, et al. Evaluation of hospital-onset bacteraemia and fungaemia in the USA as a potential healthcare quality measure: a cross-sectional study. BMJ Quality & Safety. 2024;33(8):487–498.  
  2.  Centers for Disease Control and Prevention. Current HAI progress report. Published November 4, 2022. Available at: Current HAI Progress Report | HAIs | CDC
Clinical Recommendation Statement  Healthcare facilities should implement standardized processes for the prevention, identification, treatment and monitoring of hospital-onset bacteremia and fungemia events. Patients who develop positive blood cultures during hospitalization should be evaluated to determine whether the infection represents a hospital-onset event and whether appropriate infection prevention and clinical management practices were followed. 

 Recommendations: 

  1. Healthcare facilities should maintain standardized processes for appropriate blood culture collection when bloodstream infection is clinically suspected, including adherence to recommended specimen collection techniques to reduce contamination and improve diagnostic accuracy [1]. 
  2. When a patient develops a first positive blood culture on or after hospital day 4, clinical teams should evaluate the patient for potential sources of infection, including assessment of invasive devices, recent procedures, and other possible healthcare-associated exposures [1, 2]. 
  3. Clinical management should include prompt initiation of antimicrobial therapy when bloodstream infection is suspected, followed by reassessment and modification of therapy based on microbiologic results and the patient’s clinical response, consistent with antimicrobial stewardship principles [1, 2]. 

  

References: 

  1. National Quality Forum. HospitalOnset Bacteremia and Fungemia Playbook. Washington, DC; 2024. 
  2. Dantes RB, Abbo LM, Anderson D, et al. Hospital epidemiologists’ and infection preventionists’ opinions regarding hospital-onset bacteremia and fungemia as a potential healthcare-associated infection metric. Infect Control Hosp Epidemiol. 2019;40(5):536-540. 
Improvement Notation  A lower measure score indicates higher quality. 
Definition  An HOB event occurs when a patient has a bacterial or fungal organism identified from a blood specimen collected on the 4th calendar day of admission or later (where the date of admission to an inpatient location is calendar day 1).  
  • A patient can have a single HOB event per Hospital Stay 
  • The date for the HOB will be attributed to the earliest date that a blood specimen is collected that has a bacterial or fungal organism identified on or after hospital day 4 
  • HOB Infection Timeframe: Any subsequent positive blood culture findings during the subsequent 14 days will be considered part of the initial HOB event 

 

Refer to the NHSN Bacteremia & Fungemia Surveillance Module Protocol for a complete list of definitions.  

Guidance  Bloodstream infection events are identified using positive blood culture results obtained during hospitalization. Eligible results include microbiology laboratory findings from blood specimens indicating the presence of bacterial or fungal organisms. Results derived from non-blood specimens (e.g., urine, respiratory, wound, or other body sites) are not considered for this measure. 

For the purposes of this measure, hospital-onset events are identified based on the timing of specimen collection. A blood culture specimen collected on or after hospital day 4 (where the day of admission is hospital day 1) may indicate a potential hospital-onset bacteremia or fungemia event. 

Interpretation of positive blood cultures should consider the identified organism and clinical context, as some organisms may represent contamination related to specimen collection rather than true bloodstream infection. Facilities should evaluate microbiology results in accordance with established infection surveillance and laboratory practices. 

All relevant and laboratory and microbiology data (orders and results) should be available within the EHR and exposed using the FHIR Release 4 standard. Microbiology test results should be codified using HL7 standardized terminology (e.g., appropriate laboratory and organism codes) to support consistent identification of eligible results across systems. Refer to the NHSN dQM Overview of Required FHIR Resources and Standards Adherence for additional information. 

This version of the measure uses the  Acute Care Hospital (ACH) Monthly Reporting Profiles in the NHSN dQM Content Package IG. Please refer to the NHSN FHIR Portal for additional information on FHIR-based digital quality measures. 

Initial Population  All encounters for patients of any age in an ED, observation, or inpatient location and/or all encounters for patients of any age with an ED, observation, inpatient, or short stay status that overlap the measurement period. 

Refer to the NHSN dQM Reporting Implementation Guide for the standard framework for reporting data to NHSN using a dQM with an initial population of inpatient, emergency department, and observation encounters. 

Denominator  The expected number of adult (>18 y/o) HOB events based on predictive models using facility- and patient-level data as predictors. 
Denominator Exclusions  None 
Numerator  Number of observed Hospital Onset Bacteremia and Fungemia (HOB) events during the measurement period. 

An HOB event occurs when a patient has a bacterial or fungal organism identified from a blood specimen collected on the 4th calendar day of admission or later (where the date of admission to an inpatient location is calendar day 1).  

  • A patient can have a single HOB event per Hospital Stay 
  • The date for the HOB will be attributed to the earliest date that a blood specimen is collected that has a bacterial or fungal organism identified on or after hospital day 4 
Numerator Exclusions 
  1. Bacterial skin commensals: The organism must NOT be included in the value set for bacterial skin commensals. 
  2. Previous matching COB or O-COB Event: A bacterial or fungal organism identified from a blood culture collected on hospital day 4 or later is excluded from an HOB event if the patient has an O-COB or COB event during the same Hospital Stay with at least one matching organism.  
  3. Previous HOB event: A patient with a previous HOB event is excluded from additional HOB events during the same Hospital Stay. 

 

O-COB: Outpatient Community-onset Bacteremia & Fungemia Event 

COB: Community-onset Bacteremia & Fungemia Event 

Denominator Exceptions  None 
Previous Version  None